The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)

NCT00832624 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Diabetes Mellitus Non-insulin-dependent

Interventions

DRUG: sitagliptin

Sponsor

Merck Sharp & Dohme LLC